Eurofins Scientific (France) Today

ERF Stock  EUR 46.96  0.60  1.29%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
Eurofins Scientific is trading at 46.96 as of the 25th of November 2024, a 1.29 percent increase since the beginning of the trading day. The stock's open price was 46.36. Eurofins Scientific has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Eurofins Scientific SE are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
Eurofins Scientific SE, through its subsidiaries, provides various analytical testing services worldwide. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg. EUROFINS SCIENT operates under Diagnostics Research classification in France and is traded on Paris Stock Exchange. The company has 192.56 M outstanding shares. More on Eurofins Scientific SE

Moving together with Eurofins Stock

  0.72BIM Biomerieux SAPairCorr
  0.8ALBIO BiosynexPairCorr

Moving against Eurofins Stock

  0.86CRSU Caisse RegionalePairCorr
  0.76GLE Societe GeneralePairCorr
  0.48AREIT AltareitPairCorr
  0.44AM Dassault AviationPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Eurofins Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Eurofins Scientific's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Eurofins Scientific or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationDiagnostics & Research, Healthcare (View all Sectors)
Eurofins Scientific SE (ERF) is traded on Euronext Paris in France and employs 61,000 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 12.71 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Eurofins Scientific's market, we take the total number of its shares issued and multiply it by Eurofins Scientific's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Eurofins Scientific operates under Healthcare sector and is part of Diagnostics & Research industry. The entity has 192.56 M outstanding shares. Eurofins Scientific SE has accumulated about 507.98 M in cash with 1.51 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 28.62.
Check Eurofins Scientific Probability Of Bankruptcy
Ownership Allocation
Eurofins Scientific holds a total of 192.56 Million outstanding shares. Eurofins Scientific SE retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Eurofins Ownership Details

Eurofins Scientific Risk Profiles

Although Eurofins Scientific's alpha and beta are two of the key measurements used to evaluate Eurofins Scientific's performance over the market, the standard measures of volatility play an important role as well.

Eurofins Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Eurofins Scientific without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Search Now

   

Equity Search

Search for actively traded equities including funds and ETFs from over 30 global markets
All  Next Launch Module

Eurofins Scientific Corporate Management

Elected by the shareholders, the Eurofins Scientific's board of directors comprises two types of representatives: Eurofins Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Eurofins. The board's role is to monitor Eurofins Scientific's management team and ensure that shareholders' interests are well served. Eurofins Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Eurofins Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.

Other Information on Investing in Eurofins Stock

Eurofins Scientific financial ratios help investors to determine whether Eurofins Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eurofins with respect to the benefits of owning Eurofins Scientific security.